340B Drug Pricing Program
AHA 340B Advocacy Alliance Bulletin for September 6, 2023.
Hospitals that haven’t yet filed a comment letter on the Department of Health and Human Services’ proposed remedy for the unlawful payment cuts to certain hospitals that participate in the 340B Drug Pricing Program are urged to file a letter by the new Sept. 11 deadline.
The Centers for Medicare & Medicaid Services has extended to Sept. 11 the deadline to submit comments on its proposed remedy for the unlawful payment cuts to certain hospitals that participate in the 340B Drug Pricing Program.
Southwestern Vermont Health Care (SVHC) is an integrated non-profit health system serving over 75,000 patients annually from Southwestern Vermont, parts of eastern New York, and northern Massachusetts.
As a key community institution in the heart of northern New York’s Adirondack Mountains for more than a century, Adirondack Health serves over 60,000 year-round residents and millions of visitors that frequent the region each year.
Hospitals are urged to file by the Sept. 5 deadline comment letters on the Department of Health and Human Services’ (HHS) proposed remedy for the unlawful payment cuts to certain hospitals that participate in the 340B Drug Pricing Program.
Hospitals are urged to file by the Sept. 5 deadline comment letters on the Department of Health and Human Services’ (HHS) proposed remedy for the unlawful payment cuts to certain hospitals that participate in the 340B Drug Pricing Program.
Renown Regional Medical Center prides itself on being Northern Nevada's only Level II Trauma Center with 985 licensed beds, providing care to approximately one million patients across 17 counties, encompassing 100,000 square miles between Sacramento, Calif. and Salt Lake City.
AHA urged the House Energy and Commerce Committee to consider including in its draft legislation to address drug shortages legislative proposals that would support drug manufacturers and protect the supply chain for essential medications without limiting patient access to 340B drugs.
340B Advocacy Alliance Bulletin for August 8, 2023.